Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 31, 2018

SELL
$19.02 - $24.95 $1.65 Million - $2.16 Million
-86,532 Closed
0 $0
Q1 2018

Apr 30, 2018

BUY
$22.55 - $29.9 $566,275 - $750,848
25,112 Added 40.89%
86,532 $1.98 Million
Q4 2017

Jan 31, 2018

BUY
$18.0 - $30.0 $392,022 - $653,370
21,779 Added 54.94%
61,420 $1.61 Million
Q3 2017

Nov 06, 2017

BUY
$21.1 - $25.15 $836,425 - $996,971
39,641
39,641 $890,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $162M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.